Lorazepam and Hepatobiliary disease - a phase IV clinical study of FDA data

Summary:

Hepatobiliary disease is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nexium, and have Sleep disorder.

The phase IV clinical study analyzes which people have Hepatobiliary disease when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Hepatobiliary disease?

Hepatobiliary disease (diseases affect the liver and/or biliary tract) is found to be associated with 91 drugs and 245 conditions by eHealthMe. Check the latest studies of Hepatobiliary disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

161,687 people reported to have side effects when taking Lorazepam.
Among them, 11 people (0.01%) have Hepatobiliary disease.

Could Lorazepam cause Hepatobiliary disease?

Among these 11 people:

How long have people been on Lorazepam when they have Hepatobiliary disease? *

What is the gender of people who have Hepatobiliary disease when taking Lorazepam? *

female: 60 %
male: 40 %

What is the age of people who have Hepatobiliary disease when taking Lorazepam? *

What are other drugs people take besides Lorazepam? *

What are other side effects people have besides Hepatobiliary disease? *

Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 45.45%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 3 people, 27.27%
Altered State Of Consciousness (altered state of mind): 3 people, 27.27%
Migraine (headache): 3 people, 27.27%
Neuroma (tumour of nerve tissue): 3 people, 27.27%
Aspartate Aminotransferase Increased: 3 people, 27.27%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 27.27%
Product Taste Abnormal: 3 people, 27.27%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 27.27%
Fever: 3 people, 27.27%

What are the existing conditions these people have? *

Sleep Disorder: 4 people, 36.36%
Abdominal Discomfort: 3 people, 27.27%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 27.27%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 27.27%
Asthma: 3 people, 27.27%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 27.27%
High Blood Pressure: 3 people, 27.27%
Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 3 people, 27.27%
Gastrointestinal Tract Irritation: 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and have Hepatobiliary disease?

- Check whether Hepatobiliary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorazepam:

Lorazepam (165,639 reports)

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatobiliary disease:

Hepatobiliary disease (91 drugs)

Browse all the conditions that are associated with Hepatobiliary disease:

Hepatobiliary disease (245 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.